Johnson & Johnson’s Medical Affairs team is transforming strategy with data-driven insights, moving beyond traditional approaches to identify key opinion leaders, improve advisory board diversity, and enhance patient journey mapping. With H1’s analytics, they are shifting from quantity to quality in engagements, advancing health equity, and leveraging AI for smarter decision-making.
The objective of this article is to discuss the paradigm shift in how companies plan for and deliver on the “long tail” of a drug’s impact even after Loss of Exclusivity (LoE) – a process known as lifecycle management (LCM).
This white paper draws on the collective expertise of ten leading professionals in scientific communications and stakeholder engagement, as well as members of the Medical Affairs Professional Society. Their areas of specialization include medical and scientific communications, omnichannel engagement, digital strategy, medical information and field medical operations.
Medical content is different from promotional content – it’s all about clinical data, real-world evidence, and scientific narratives. So, as you adopt a modular strategy for your medical content, why use a promotional approach?
In an era of data-driven medical communications, we’re missing a crucial ingredient: storytelling. New research shows our brains are wired to engage with narrative formats – making storytelling not just a ‘nice-to-have’ but a neurological necessity for effective medical education. Learn how the STORIES framework (Structure, Tailoring, Originality, Rationality, Immediacy, Emotionality, Simplicity) is revolutionizing how we communicate complex medical information to healthcare providers and patients alike. From graphic novels to VR simulations, see how narrative techniques are transforming medical education and patient engagement.
The objective of this White Paper is to guide Medical Affairs personnel on the key components of the legal, regulatory, and industry codes of practice requirements which are applicable to Medical Affairs in Pharma and Medical Devices industries, and how to identify and mitigate risks. This paper also includes company control frameworks for compliance with the requirements through policies, processes (usually captured in Standard Operating Procedures [SOPs]), systems, training, monitoring, and audit.
Altmetric’s top 10 most interesting publications of 2024
Medical Affairs is uniquely positioned as the only department capable of impacting the Enterprise Commercialization Process (ECP) at every stage, from the initial product concept through the entire commercialization effort.
This article explores key questions on how Medical Affairs teams manage patient engagement across different-sized companies who have variations in focus, resources, and scale.
This article based on the Oct 3, 2024 Insights FAWG Forum explores the potential for artificial intelligence (AI) to transform Medical Affairs, focusing on medical insights.